Ethema Health Corp (GRST)

[Bubae]

It would be nice to see some links to information for the $4.5 million figure that you are quoting. The fact is the Leons have put very little money at risk in shares of this stock and nowhere near $4.5 million for total investment.

Shawn Leon, the CEO, sold Cranberry Cove Holdings Ltd. which holds the Canadian property to the shareholders of Ethema (GSRT).
This is where 60 million shares of Leon developments came from, not an investment by the Leons. Teh bit over 900K owed to Leon Developments may be part of that deal, i am not digging for it.

The son came by his shares through the $25K for 100 million shares for .00025 a share. That was a deal his mom did, again no big money at risk.

Eileen Greene, the spouse of the CEO, took 4 million Series A Preferred shares for $40K advanced to the company, that money isn't at risk with a reverse split of the common.

The last time the CEO bought shares was in 2018. That purchase was 80,417,584 million shares for $28,350 or .079 a share. That doesn't even dent the $4.5 million figure being thrown around. The summary below, in red, of stock ownership shows that the Leons have little at risk related to the share structure destruction. In fact these are wealthy people who's tax accountant probably wouldn't mind a few deductions.


Shawn Leon form 4 2018
https://sec.report/Document/0001721868-18-000742/



The Share Purchase Agreement

Under the SPA, the Company acquired 100% of the stock of CCH from Leon Developments Ltd. (“Leon Developments”), a company wholly owned by Shawn E. Leon, who is the President, CEO, and CFO of the Company (“Mr. Leon”). CCH owns the real estate on which GreeneStone Muskoka is located. The total consideration paid by the Company was CDN$3,517,062, including the assumption of certain liabilities of CCH, which was funded by the assignment to Leon Developments of certain indebtedness owing to the Company in the amount of CDN$659,918, and the issuance of 60,000,000 shares of the Company’s common stock to Leon Developments, valued at US$0.0364 per share.

"During December 2020, the Company issued 4,000,000 Series A Preferred shares at par value of $0.01 per share to Eileen Greene, the spouse of our CEO, in settlement of $40,000 of advances made to the Company."


2020 10K annual filing
shttps://sec.report/Document/0001721868-21-000220/
The following table sets forth the beneficial ownership of our capital stock by each executive officer and director, by each person known by us to beneficially own more than five percent (5%) of any class of stock and by the executive officers and directors as a group. Except as otherwise indicated, all shares of common stock are owned directly and the percentage shown is based on 2,262,849,130 shares of common Stock issued and outstanding as of April 12, 2021.



Name of beneficial owner Amount and
nature of beneficial
ownership,
including common
stock Percentage of
common stock
beneficially owned(1)

Directors and Officers
Shawn E. Leon 171,864,342 (2)

(2) Includes 500,000 shares held by Mr. Leon, a further 2,687,300 shares held by Greenestone Clinic, a company controlled by Mr. Leon, a further 60,000,000 shares owned by Leon Developments, a company controlled by Mr. Leon , 8,677,042 shares owned by Eileen Greene, Mr. Leon's spouse and 100,000,000 shares owned by Mr. Leon’s’ son.